Roche Diagnostics Malaysia, a leading provider in in-vitro diagnostics, showcases its latest technological solutions in lab automation and highlights the company’s vision for transforming patient care through breakthrough diagnostic solutions its inaugural Roche Innovation Day.
The event was attended by the Swiss Ambassador to Malaysia, Her Excellency Ms. Andrea Reichlin, Clinical Research Malaysia (CRM), Malaysian Healthcare Travel Council (MHTC), InvestKL, as well as clinicians, pathologists and laboratory technicians from 66 public and private institutions throughout Malaysia.
In-vitro diagnostics (diagnostic testing done outside the body) influence over 60 percent of clinical decisions decision along the entire continuum of a patient’s health journey. But it only accounts for about 2 percent of the total healthcare spending in the clinical setting worldwide. With Malaysia’s increasing burden of disease and government spending, diagnostics can emerge as a critical driver in Malaysia’s healthcare ecosystem.
Heng Chai Yin, General Manager of Roche Diagnostics Malaysia said, “The healthcare environment today is characterised by the rising burden of chronic diseases, an ageing population but also escalating healthcare costs. Our aim is to work alongside laboratories and other healthcare providers to address these challenges so that together we can realise our vision of improving the lives of patients. We remain as committed today as we did when we first launched our operations in Malaysia, more than 20 years ago.”
“With the prevalence of non-communicable diseases such as cardiovascular diseases being on the rise in Malaysia, we are working closely with government and private healthcare institutions and diagnostics labs across the country to provide innovative diagnostics solutions which can help save lives,” Heng added.
Roche Diagnostics’ continuous commitment to adding value to Malaysia by ways of introducing innovation into the public sector, advancing the medical travel industry, and enabling the transformation of Malaysia into a cardiology and fertility hub.
